BRAF mutations in papillary thyroid carcinoma and emerging targeted therapies
GC Leonardi, S Candido… - Molecular …, 2012 - spandidos-publications.com
Papillary thyroid carcinoma (PTC) is the most common histotype among the thyroid cancer
types. Although PTC is a curable malignancy, many patients relapse after treatment. Thus …
types. Although PTC is a curable malignancy, many patients relapse after treatment. Thus …
Clinical impact of the detection of BRAF mutations in thyroid pathology: potential usefulness as diagnostic, prognostic and theragnostic applications
S Lassalle, V Hofman, M Ilie, C Butori… - Current medicinal …, 2010 - ingentaconnect.com
A BRAF somatic mutation at residue 600 of the BRAF protein (BRAFV600E) is highly
prevalent in papillary thyroid carcinomas (PTC). This mutation occurs in approximately …
prevalent in papillary thyroid carcinomas (PTC). This mutation occurs in approximately …
Prognostic role of 18F-FDG PET/CT in the postoperative evaluation of differentiated thyroid cancer patients
Purpose The aim of this study was to evaluate the role of 18 F-FDG PET/CT performed after
surgery but before radioiodine therapy in patients with differentiated thyroid cancer …
surgery but before radioiodine therapy in patients with differentiated thyroid cancer …
[HTML][HTML] Telomerase reverse transcriptase induced thyroid carcinoma cell proliferation through PTEN/AKT signaling pathway
H Zhang, N Hu - Molecular medicine reports, 2018 - spandidos-publications.com
Thyroid carcinoma is the most common endocrine malignant tumor in the world, and so,
there is a requirement to develop novel molecular targets for thyroid cancer diagnosis and …
there is a requirement to develop novel molecular targets for thyroid cancer diagnosis and …
The purine receptor P2X7R regulates the release of pro-inflammatory cytokines in human craniopharyngioma
J Nie, G Huang, SZ Deng, Y Bao… - Endocrine-Related …, 2017 - erc.bioscientifica.com
Craniopharyngiomas (CPs) are usually benign, non-metastasizing embryonic malformations
originating from the sellar area. They are, however, locally invasive and generate adherent …
originating from the sellar area. They are, however, locally invasive and generate adherent …
Comparison of diagnostic and prognostic capabilities of 18F-FDG-PET/CT, 131I-scintigraphy, and diffusion-weighted magnetic resonance imaging for postoperative …
S Nagamachi, H Wakamatsu, S Kiyohara… - Japanese journal of …, 2011 - Springer
Purpose The first aim of this study was to compare the detectability of metastasis of
postoperative differentiated thyroid cancer (DTC) among 131 I whole body scintigraphy …
postoperative differentiated thyroid cancer (DTC) among 131 I whole body scintigraphy …
Recent advances in molecular diagnosis of thyroid cancer
Recent molecular studies have described a number of abnormalities associated with the
progression and dedifferentiation of thyroid carcinoma. These distinct molecular events are …
progression and dedifferentiation of thyroid carcinoma. These distinct molecular events are …
Evaluation of PTEN, PI3K, MTOR, and KRAS expression and their clinical and prognostic relevance to differentiated thyroid carcinoma
BB Duman, OI Kara, A Uğuz, BT Ates - Contemporary Oncology …, 2014 - termedia.pl
Results: A significant correlation was found between p85 expression and lymphovascular
invasions and between PTEN expression and multifocality (p= 0.048 and p= 0.04 …
invasions and between PTEN expression and multifocality (p= 0.048 and p= 0.04 …
Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone …
ZL Qiu, YL Xue, HJ Song, QY Luo - Nuclear medicine …, 2012 - journals.lww.com
Objective The aim of this study was to compare the diagnostic and prognostic values of 99m
Tc-MDP-planar bone scintigraphy (99m Tc-MDP-BS), 131 I single-photon emission …
Tc-MDP-planar bone scintigraphy (99m Tc-MDP-BS), 131 I single-photon emission …
Overexpression of miR-375 and L-type amino acid Transporter 1 in pheochromocytoma and their molecular and functional implications
Pheochromocytoma (Pheo) is a tumor derived from chromaffin cells. It can be studied using
18F-dihydroxyphenylalanine (DOPA)—positron emission tomography (PET) due to its …
18F-dihydroxyphenylalanine (DOPA)—positron emission tomography (PET) due to its …